Orthofix Medical Inc. (OFIX)
USD 13.79
(1.77%)
USD 13.79
(1.77%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -86.98 Million USD | -272.34% |
| 2022 | 12.6 Million USD | -188.69% |
| 2021 | 17.94 Million USD | -25.16% |
| 2020 | 32.66 Million USD | -27.7% |
| 2019 | -2.22 Million USD | 37.01% |
| 2018 | 41.54 Million USD | 1.08% |
| 2017 | 60.93 Million USD | -9.13% |
| 2016 | 39.86 Million USD | 43.85% |
| 2015 | 29.91 Million USD | -45.86% |
| 2014 | 40.63 Million USD | -38.12% |
| 2013 | 14.04 Million USD | -26.42% |
| 2012 | 96.18 Million USD | -0.46% |
| 2011 | 53.26 Million USD | 0.5% |
| 2010 | 112.14 Million USD | 30.61% |
| 2009 | 87.18 Million USD | 3.7% |
| 2008 | -243.52 Million USD | -26.64% |
| 2007 | 70.39 Million USD | 404.27% |
| 2006 | 25.81 Million USD | -38.28% |
| 2005 | 116.75 Million USD | -48.86% |
| 2004 | 70.08 Million USD | 29.44% |
| 2003 | 47.53 Million USD | 5.74% |
| 2002 | 48.76 Million USD | 32.36% |
| 2001 | 38.44 Million USD | 1133.85% |
| 2000 | 41.51 Million USD | -89.53% |
| 1999 | 30.04 Million USD | 74.62% |
| 1998 | 21.76 Million USD | -7.53% |
| 1997 | 17.56 Million USD | 28.28% |
| 1996 | 12.8 Million USD | -55.79% |
| 1995 | 9.7 Million USD | 182.76% |
| 1994 | 12.7 Million USD | 5.45% |
| 1993 | 11.3 Million USD | 25.0% |
| 1992 | 9.1 Million USD | -57.89% |
| 1991 | 20.9 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -7.7 Million USD | 15.02% |
| 2024 Q1 | -13.3 Million USD | -339.92% |
| 2023 Q1 | -54.9 Million USD | -1124.44% |
| 2023 FY | - USD | -272.34% |
| 2023 Q2 | -23 Million USD | 58.11% |
| 2023 Q3 | -23.23 Million USD | -1.03% |
| 2023 Q4 | -4.89 Million USD | 78.93% |
| 2022 Q1 | -1.2 Million USD | -107.61% |
| 2022 Q3 | -357 Thousand USD | -2331.25% |
| 2022 FY | - USD | -188.69% |
| 2022 Q2 | 16 Thousand USD | 101.33% |
| 2022 Q4 | -4.48 Million USD | -1156.02% |
| 2021 FY | - USD | -25.16% |
| 2021 Q1 | 5.22 Million USD | -80.12% |
| 2021 Q2 | 12.59 Million USD | 140.95% |
| 2021 Q3 | 3.61 Million USD | -71.29% |
| 2021 Q4 | 15.76 Million USD | 336.15% |
| 2020 Q3 | 16.38 Million USD | 382.53% |
| 2020 Q1 | 5.8 Million USD | -33.82% |
| 2020 Q4 | 26.28 Million USD | 60.43% |
| 2020 FY | - USD | -27.7% |
| 2020 Q2 | -5.79 Million USD | -199.88% |
| 2019 Q1 | 14.96 Million USD | 13.71% |
| 2019 Q2 | 11.22 Million USD | -25.02% |
| 2019 Q3 | 35.58 Million USD | 217.08% |
| 2019 Q4 | 8.77 Million USD | -75.34% |
| 2019 FY | - USD | 37.01% |
| 2018 Q4 | 13.16 Million USD | 11.5% |
| 2018 FY | - USD | 1.08% |
| 2018 Q2 | 11.57 Million USD | -5.42% |
| 2018 Q3 | 11.8 Million USD | 1.96% |
| 2018 Q1 | 12.24 Million USD | 33.18% |
| 2017 Q1 | 10.99 Million USD | 29.89% |
| 2017 Q4 | 9.19 Million USD | -34.38% |
| 2017 Q3 | 14 Million USD | 4.77% |
| 2017 FY | - USD | -9.13% |
| 2017 Q2 | 13.37 Million USD | 21.61% |
| 2016 FY | - USD | 43.85% |
| 2016 Q4 | 8.46 Million USD | -30.35% |
| 2016 Q1 | 7.61 Million USD | 8.92% |
| 2016 Q3 | 12.15 Million USD | 7.33% |
| 2016 Q2 | 11.32 Million USD | 48.62% |
| 2015 Q3 | 6.43 Million USD | -31.23% |
| 2015 Q1 | 5.04 Million USD | -48.49% |
| 2015 FY | - USD | -45.86% |
| 2015 Q2 | 9.35 Million USD | 85.41% |
| 2015 Q4 | 6.99 Million USD | 8.72% |
| 2014 Q1 | 25.08 Million USD | 65.61% |
| 2014 Q4 | 9.79 Million USD | -16.06% |
| 2014 Q2 | 16.87 Million USD | -32.74% |
| 2014 FY | - USD | -38.12% |
| 2014 Q3 | 11.66 Million USD | -30.84% |
| 2013 Q3 | 33.36 Million USD | 138.01% |
| 2013 FY | - USD | -26.42% |
| 2013 Q4 | 15.14 Million USD | -54.61% |
| 2013 Q2 | 14.01 Million USD | 55.43% |
| 2013 Q1 | 9.01 Million USD | -69.49% |
| 2012 Q4 | 29.56 Million USD | 13.78% |
| 2012 FY | - USD | -0.46% |
| 2012 Q1 | 27.71 Million USD | -16.74% |
| 2012 Q2 | 27.98 Million USD | 0.99% |
| 2012 Q3 | 25.98 Million USD | -7.16% |
| 2011 FY | - USD | 0.5% |
| 2011 Q4 | 33.28 Million USD | 14.9% |
| 2011 Q2 | 24.86 Million USD | 226.56% |
| 2011 Q3 | 28.96 Million USD | 16.48% |
| 2011 Q1 | -19.64 Million USD | -181.25% |
| 2010 FY | - USD | 30.61% |
| 2010 Q4 | 24.18 Million USD | -4.73% |
| 2010 Q1 | 24.79 Million USD | -12.86% |
| 2010 Q2 | 26.15 Million USD | 5.51% |
| 2010 Q3 | 25.38 Million USD | -2.96% |
| 2009 Q4 | 28.45 Million USD | 22.63% |
| 2009 Q3 | 23.2 Million USD | 51.76% |
| 2009 Q1 | 15.71 Million USD | -46.46% |
| 2009 Q2 | 15.28 Million USD | -2.73% |
| 2009 FY | - USD | 3.7% |
| 2008 Q4 | 29.35 Million USD | 76.64% |
| 2008 Q1 | 17.47 Million USD | -57.67% |
| 2008 Q2 | 18.65 Million USD | 6.77% |
| 2008 FY | - USD | -26.64% |
| 2008 Q3 | 16.61 Million USD | -10.9% |
| 2007 FY | - USD | 404.27% |
| 2007 Q4 | 41.27 Million USD | 73.32% |
| 2007 Q1 | 22.59 Million USD | 50.59% |
| 2007 Q3 | 23.81 Million USD | -1.68% |
| 2007 Q2 | 24.22 Million USD | 7.19% |
| 2006 Q2 | 18.25 Million USD | 26.84% |
| 2006 FY | - USD | -38.28% |
| 2006 Q4 | 15 Million USD | 157.71% |
| 2006 Q1 | 14.39 Million USD | -29.27% |
| 2006 Q3 | -26 Million USD | -242.42% |
| 2005 Q2 | 20.96 Million USD | 19.87% |
| 2005 FY | - USD | -48.86% |
| 2005 Q4 | 20.35 Million USD | 187.12% |
| 2005 Q3 | -23.36 Million USD | -211.43% |
| 2005 Q1 | 17.49 Million USD | -2.36% |
| 2004 Q1 | 16.1 Million USD | 6.89% |
| 2004 Q3 | 18.77 Million USD | 7.09% |
| 2004 Q2 | 17.53 Million USD | 8.91% |
| 2004 Q4 | 17.91 Million USD | -4.61% |
| 2004 FY | - USD | 29.44% |
| 2003 Q3 | 10.4 Million USD | 1.96% |
| 2003 FY | - USD | 5.74% |
| 2003 Q1 | 11.37 Million USD | 4.84% |
| 2003 Q2 | 11.98 Million USD | 5.3% |
| 2003 Q4 | 13.76 Million USD | 11.7% |
| 2002 Q3 | 10.68 Million USD | -4.7% |
| 2002 Q1 | 10.32 Million USD | 111.93% |
| 2002 Q2 | 11.46 Million USD | 14.4% |
| 2002 FY | - USD | 32.36% |
| 2002 Q4 | 11.17 Million USD | 3.68% |
| 2001 Q4 | -88.86 Million USD | -321.28% |
| 2001 Q3 | 40.15 Million USD | 364.52% |
| 2001 Q1 | 8.6 Million USD | -54.72% |
| 2001 Q2 | 8.52 Million USD | 1.98% |
| 2001 FY | - USD | 1133.85% |
| 2000 Q1 | 7.26 Million USD | -380.54% |
| 2000 Q4 | 18.72 Million USD | 178.6% |
| 2000 Q3 | 6.9 Million USD | 0.33% |
| 2000 FY | - USD | -89.53% |
| 2000 Q2 | 7.26 Million USD | 123.1% |
| 1999 FY | - USD | 74.62% |
| 1999 Q2 | 6.4 Million USD | 1.56% |
| 1999 Q4 | 10.74 Million USD | 49.78% |
| 1999 Q3 | 6.59 Million USD | 6.15% |
| 1999 Q1 | 6.31 Million USD | 110.39% |
| 1998 Q3 | 26.4 Million USD | 3.53% |
| 1998 FY | - USD | -7.53% |
| 1998 Q4 | -61.6 Million USD | -333.33% |
| 1998 Q1 | 25 Million USD | 145.7% |
| 1998 Q2 | 25.5 Million USD | 2.0% |
| 1997 Q2 | 22.4 Million USD | 8.74% |
| 1997 FY | - USD | 28.28% |
| 1997 Q4 | -54.7 Million USD | -339.91% |
| 1997 Q3 | 22.8 Million USD | 1.79% |
| 1997 Q1 | 20.6 Million USD | 140.71% |
| 1996 Q3 | 19.2 Million USD | 1.05% |
| 1996 Q4 | -50.6 Million USD | -363.54% |
| 1996 Q2 | 19 Million USD | 0.0% |
| 1996 FY | - USD | -55.79% |
| 1996 Q1 | 19 Million USD | 167.86% |
| 1995 FY | - USD | 182.76% |
| 1995 Q4 | -28 Million USD | -325.81% |
| 1995 Q1 | 2.7 Million USD | 115.88% |
| 1995 Q2 | 11.6 Million USD | 329.63% |
| 1995 Q3 | 12.4 Million USD | 6.9% |
| 1994 Q4 | -17 Million USD | -275.26% |
| 1994 Q2 | 2.5 Million USD | -73.12% |
| 1994 Q1 | 9.3 Million USD | 176.23% |
| 1994 FY | - USD | 5.45% |
| 1994 Q3 | 9.7 Million USD | 288.0% |
| 1993 Q4 | -12.2 Million USD | -269.44% |
| 1993 FY | - USD | 25.0% |
| 1993 Q3 | 7.2 Million USD | -6.49% |
| 1993 Q2 | 7.7 Million USD | -1.28% |
| 1993 Q1 | 7.8 Million USD | 162.9% |
| 1992 Q1 | 7.1 Million USD | 33.96% |
| 1992 FY | - USD | -57.89% |
| 1992 Q4 | -12.4 Million USD | -279.71% |
| 1992 Q3 | 6.9 Million USD | 4.55% |
| 1992 Q2 | 6.6 Million USD | -7.04% |
| 1991 Q3 | 5.2 Million USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q1 | 5.2 Million USD | 0.0% |
| 1991 Q2 | 5.2 Million USD | 0.0% |
| 1991 Q4 | 5.3 Million USD | 1.92% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AdaptHealth Corp. | -171.09 Million USD | 49.159% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 3557.273% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | -74.77% |
| BrainsWay Ltd. | -2.31 Million USD | -3663.955% |
| Cerus Corporation | -26.53 Million USD | -227.8% |
| CVRx, Inc. | -38.73 Million USD | -124.588% |
| electroCore, Inc. | -17.76 Million USD | -389.78% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -1313.013% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -639.921% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -618.469% |
| Treace Medical Concepts, Inc. | -39 Million USD | -122.993% |
| iCAD, Inc. | -6.56 Million USD | -1224.981% |
| IceCure Medical Ltd | -15.25 Million USD | -470.281% |
| 908 Devices Inc. | -34.02 Million USD | -155.65% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -700.23% |
| Movano Inc. | -29.12 Million USD | -198.661% |
| MaxCyte, Inc. | -44.12 Million USD | -97.12% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1428.186% |
| PAVmed Inc | -75.74 Million USD | -14.844% |
| Insulet Corporation | 323.6 Million USD | 126.88% |
| Quanterix Corporation | -38.08 Million USD | -128.379% |
| RxSight, Inc. | -41.03 Million USD | -111.967% |
| Sight Sciences, Inc. | -49.41 Million USD | -76.03% |
| Sintx Technologies, Inc. | -6.6 Million USD | -1217.955% |
| Surmodics, Inc. | 1.18 Million USD | 7421.97% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | -49.208% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -421.649% |
| Venus Concept Inc. | -26.11 Million USD | -233.11% |
| NeuroPace, Inc. | -22.83 Million USD | -280.945% |
| LENSAR, Inc. | -8.71 Million USD | -898.221% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | -61.808% |
| SI-BONE, Inc. | -34.44 Million USD | -152.526% |
| TELA Bio, Inc. | -40.63 Million USD | -114.075% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -978.951% |
| Lucid Diagnostics Inc. | -49.75 Million USD | -74.841% |
| LivaNova PLC | 39.01 Million USD | 322.947% |
| Bioventus Inc. | -23.07 Million USD | -277.048% |
| Envoy Medical, Inc. | -18.23 Million USD | -376.944% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -1873.344% |
| Spectral AI, Inc. | -12.26 Million USD | -609.387% |
| Nano-X Imaging Ltd. | -47.69 Million USD | -82.385% |
| Aethlon Medical, Inc. | -11.84 Million USD | -634.105% |
| Inogen, Inc. | -45.67 Million USD | -90.427% |
| OrthoPediatrics Corp. | -8.38 Million USD | -937.883% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 21.346% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -2365.561% |
| Apyx Medical Corporation | -18.11 Million USD | -380.262% |
| Cutera, Inc. | -136.56 Million USD | 36.303% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -2473.521% |
| BioSig Technologies, Inc. | -28.15 Million USD | -208.994% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -314.431% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 122.678% |
| Axonics, Inc. | 7.77 Million USD | 1218.778% |
| Outset Medical, Inc. | -153.78 Million USD | 43.439% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -416.057% |
| IRIDEX Corporation | -7.44 Million USD | -1067.897% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 11.326% |
| IRadimed Corporation | 20.8 Million USD | 518.184% |
| INVO Bioscience, Inc. | -6.88 Million USD | -1164.313% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 337.165% |
| Varex Imaging Corporation | 67.2 Million USD | 229.442% |
| Quipt Home Medical Corp. | 44.07 Million USD | 297.375% |
| BIOLASE, Inc. | -15.13 Million USD | -474.576% |
| Beyond Air, Inc. | -59.03 Million USD | -47.355% |
| Pulmonx Corporation | -55.09 Million USD | -57.89% |
| Modular Medical, Inc. | -17.1 Million USD | -408.595% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -500.518% |
| FONAR Corporation | 28.25 Million USD | 407.894% |
| Semler Scientific, Inc. | 23.58 Million USD | 468.752% |
| InMode Ltd. | 196.28 Million USD | 144.316% |
| Bruker Corporation | 599 Million USD | 114.522% |
| Cytosorbents Corporation | -28.81 Million USD | -201.918% |
| DexCom, Inc. | 916.7 Million USD | 109.489% |
| Align Technology, Inc. | 799.03 Million USD | 110.886% |
| ZimVie Inc. | 91.07 Million USD | 195.511% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1428.186% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -2365.561% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 55.314% |
| Profound Medical Corp. | -27.12 Million USD | -220.7% |
| Vivani Medical, Inc. | -26.6 Million USD | -226.913% |
| enVVeno Medical Corporation | -25.01 Million USD | -247.69% |
| Inari Medical, Inc. | 7.11 Million USD | 1322.902% |
| UFP Technologies, Inc. | 72.74 Million USD | 219.579% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -2469.123% |
| Nuwellis, Inc. | -16.35 Million USD | -431.823% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 10.197% |
| InspireMD, Inc. | -20.91 Million USD | -315.977% |
| PAVmed Inc. | -75.74 Million USD | -14.844% |
| AxoGen, Inc. | -13.32 Million USD | -552.649% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 454.448% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -109.725% |
| Tenon Medical, Inc. | -15.52 Million USD | -460.182% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -469.796% |
| NanoVibronix, Inc. | -3.43 Million USD | -2432.314% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -700.23% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 290050.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 68.629% |
| TransMedics Group, Inc. | -7.6 Million USD | -1044.088% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -299.655% |
| NeuroMetrix, Inc. | -7.09 Million USD | -1125.864% |
| Hyperfine, Inc. | -47.06 Million USD | -84.835% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | -49.184% |
| Biomerica, Inc. | -5.99 Million USD | -1351.443% |
| Bone Biologics Corporation | 479.57 Thousand USD | 18238.048% |
| AVITA Medical, Inc. | -39.56 Million USD | -119.838% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -848.279% |
| Silk Road Medical, Inc | -45.08 Million USD | -92.957% |